ArticleBioengineered2022

Novel glucagon-like peptide-1 analogue exhibits potency-driven G-protein biased agonism with promising effects on diabetes and diabetic dry eye syndrome.

Yongna Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.